Physician profile
Vinay Kapoor
NPI 1952491698
$819,886.33
in general payments reported to CMS, 2019-2025
52 companies · $146K in 2025
The $146K reported for 2025 was more than what 99% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107K · 2020: $56K · 2021: $94K · 2022: $134K · 2023: $114K · 2024: $169K · 2025: $146K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $317K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $43K · Food and Beverage: $28K · Honoraria: $26K · Travel and Lodging: $8,187 · Consulting Fee: $6,175 · Education: $52.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $317,015.27 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $43,275.00 |
| Food and Beverage | $28,226.94 |
| Honoraria | $26,075.00 |
| Travel and Lodging | $8,187.22 |
| Consulting Fee | $6,175.00 |
| Education | $52.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $241,245.36 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $80,380.21 | 2019-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $72,917.80 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $62,828.54 | 2019-2025 | Farxiga, Breztri |
| Intuity Medical INC | $49,257.14 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Amgen INC. | $46,651.70 | 2019-2025 | Tepezza, Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $43,070.63 | 2021-2025 | |
| Abbott Laboratories | $41,724.63 | 2019-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39,588.00 | 2020-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $39,155.43 | 2019-2025 | |
| Cequr Corporation | $35,557.24 | 2022-2025 | Cequr Simplicity |
| Xeris Pharmaceuticals, INC. | $19,126.34 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Merck Sharp & Dohme LLC | $15,117.68 | 2019-2023 | Steglatro |
| Lilly USA, LLC | $13,677.82 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Horizon Therapeutics Plc | $12,581.74 | 2021-2023 | Tepezza |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $1,854.78 | 2025 | Rezdiffra |
| Amneal Pharmaceuticals LLC | $843.68 | 2021-2025 | Unithroid |
| Abbvie INC. | $703.96 | 2019-2025 | |
| Currax Pharmaceuticals LLC | $578.77 | 2020-2025 | Contrave, Onzetra Xsail, Nexletol |
| Lifescan, INC. | $328.09 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $323.80 | 2020-2025 | Strensiq |
| Ascendis Pharma Endocrinology INC | $302.09 | 2023-2025 | Yorvipath |
| Amarin Pharma, INC. | $283.47 | 2019-2023 | |
| Corcept Therapeutics | $229.90 | 2021-2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $216.07 | 2022-2025 | |
| Tandem Diabetes Care, INC. | $172.13 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Esperion Therapeutics, INC. | $159.93 | 2020-2021 | |
| Grt US Holding, INC. | $147.01 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $90.45 | 2020-2021 | |
| Althera Pharmaceuticals LLC | $82.58 | 2021-2022 | |
| Sequel Med Tech, LLC | $79.48 | 2025 | Twiist |
| Mannkind Corporation | $75.09 | 2019-2024 | |
| Amphastar Pharmaceuticals, INC. | $61.10 | 2024-2025 | |
| Beta Bionics, INC. | $50.19 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Astellas Pharma US INC | $49.08 | 2025 | Veozah |
| Ultragenyx Pharmaceutical INC. | $40.53 | 2020-2022 | |
| Antares Pharma, INC. | $34.20 | 2024 | Xyosted |
| Pfizer INC. | $28.60 | 2024 | |
| Amryt Pharma Holdings Ltd | $24.37 | 2022 | |
| Insulet Corporation | $23.94 | 2019 | |
| Kyowa Kirin, INC. | $22.50 | 2023 | Crysvita |
| Allergan, INC. | $22.32 | 2019 | |
| Intra-Sana Laboratories | $21.00 | 2023 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Nalpropion Pharmaceuticals LLC | $19.53 | 2019 | |
| Averitas Pharma INC. | $18.38 | 2025 | Qutenza |
| Aimmune Therapeutics, INC. | $18.15 | 2024 | |
| Ascensia Diabetes Care US INC. | $18.05 | 2025 | |
| Ironwood Pharmaceuticals, INC | $16.98 | 2023 | Linzess |
| Lexicon Pharmaceuticals, INC. | $15.87 | 2023 | Inpefa |
| Glaxosmithkline, LLC. | $15.00 | 2020 | |
| Companion Medical, INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinay Kapoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.